225 related articles for article (PubMed ID: 30471375)
1. A big data approach to pharmaceutical flow properties.
Megarry AJ; Swainson SME; Roberts RJ; Reynolds GK
Int J Pharm; 2019 Jan; 555():337-345. PubMed ID: 30471375
[TBL] [Abstract][Full Text] [Related]
2. Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Schubert MA; Vervaet C; De Beer T
Eur J Pharm Biopharm; 2019 Feb; 135():49-60. PubMed ID: 30582959
[TBL] [Abstract][Full Text] [Related]
3. On the relationship of inter-particle cohesiveness and bulk powder behavior: Flowability of pharmaceutical powders.
Capece M; Silva KR; Sunkara D; Strong J; Gao P
Int J Pharm; 2016 Sep; 511(1):178-189. PubMed ID: 27353729
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and prediction of powder flowability in pharmaceutical tableting.
Hildebrandt C; Gopireddy SR; Fritsch AK; Profitlich T; Scherließ R; Urbanetz NA
Pharm Dev Technol; 2019 Jan; 24(1):35-47. PubMed ID: 29227171
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach.
Santos B; Carmo F; Schlindwein W; Muirhead G; Rodrigues C; Cabral L; Westrup J; Pitt K
Drug Dev Ind Pharm; 2018 Dec; 44(12):2089-2097. PubMed ID: 30113219
[TBL] [Abstract][Full Text] [Related]
7. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension.
Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P
J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726
[TBL] [Abstract][Full Text] [Related]
9. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
[TBL] [Abstract][Full Text] [Related]
10. Flow rate and flow equation of pharmaceutical free-flowable powder excipients.
Sklubalová Z; Zatloukal Z
Pharm Dev Technol; 2013 Feb; 18(1):106-11. PubMed ID: 22149908
[TBL] [Abstract][Full Text] [Related]
11. FIP Guidelines for Dissolution Testing of Solid Oral Products.
Friedel HD; Brown CK; Barker AR; Buhse LF; Keitel S; Kraemer J; Morris JM; Reppas C; Sperry DC; Sakai-Kato K; Stickelmeyer MP; Shah VP
J Pharm Sci; 2018 Dec; 107(12):2995-3002. PubMed ID: 30148985
[TBL] [Abstract][Full Text] [Related]
12. Particle Engineering Via Mechanical Dry Coating in the Design of Pharmaceutical Solid Dosage Forms.
Qu L; Morton DA; Zhou QT
Curr Pharm Des; 2015; 21(40):5802-14. PubMed ID: 26446461
[TBL] [Abstract][Full Text] [Related]
13. Advanced microscopy techniques to assess solid-state properties of inhalation medicines.
Shur J; Price R
Adv Drug Deliv Rev; 2012 Mar; 64(4):369-82. PubMed ID: 22120022
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
15. Potential of Powder Rheology for Detecting Unforeseen Cross-Contamination of Foreign Active Pharmaceutical Ingredients.
Setoguchi S; Goto S; Matsunaga K
AAPS PharmSciTech; 2024 Jun; 25(6):138. PubMed ID: 38890193
[TBL] [Abstract][Full Text] [Related]
16. Applications of various analytical techniques in quality control of pharmaceutical excipients.
Kumar M; Bhatia R; Rawal RK
J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
[TBL] [Abstract][Full Text] [Related]
17. Effect of colloidal silica on rheological properties of common pharmaceutical excipients.
Majerová D; Kulaviak L; Růžička M; Štěpánek F; Zámostný P
Eur J Pharm Biopharm; 2016 Sep; 106():2-8. PubMed ID: 27163240
[TBL] [Abstract][Full Text] [Related]
18. Liquisolid systems and aspects influencing their research and development.
Vraníková B; Gajdziok J
Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
[TBL] [Abstract][Full Text] [Related]
19. Practical methods for improving flow properties of active pharmaceutical ingredients.
Pingali KC; Saranteas K; Foroughi R; Muzzio FJ
Drug Dev Ind Pharm; 2009 Dec; 35(12):1460-9. PubMed ID: 19929205
[TBL] [Abstract][Full Text] [Related]
20. Surface engineered excipients: I. improved functional properties of fine grade microcrystalline cellulose.
Chen L; Ding X; He Z; Huang Z; Kunnath KT; Zheng K; Davé RN
Int J Pharm; 2018 Jan; 536(1):127-137. PubMed ID: 29191481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
